Shenzhen Mindray Bio-Med
ISIN CNE100003G67
|WKN A2PG6H
Overview
Description
Shenzhen Mindray Bio-Medical Electronics Co. Ltd. se consacre à la recherche et au développement, à la fabrication, à la commercialisation et au service de dispositifs médicaux. Ses produits comprennent la surveillance des patients, les ultrasons, l'anesthésie, les diagnostics in vitro et les produits remis à neuf. L'entreprise a été fondée par Hang Xu le 25 janvier 1991 et son siège social se trouve à Shenzhen, en Chine.
Santé Équipements de soins de santé Matériel médical général Chine
Financials
Key metrics
| Market capitalisation, EUR | 32 446,28 M |
| EPS, EUR | 1,31 |
| P/B ratio | 7,23 |
| P/E ratio | 21,66 |
| Dividend yield | 3,25% |
Income statement (2023)
| Revenue, EUR | 4 517,24 M |
| Net income, EUR | 1 513,63 M |
| Profit margin | 33,51% |
What ETF is Shenzhen Mindray Bio-Med in?
There are 149 ETFs which contain Shenzhen Mindray Bio-Med. All of these ETFs are listed in the table below. The ETF with the largest weighting of Shenzhen Mindray Bio-Med is the Invesco ChiNext 50 UCITS ETF Acc.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
